全文获取类型
收费全文 | 5320篇 |
免费 | 354篇 |
国内免费 | 109篇 |
专业分类
耳鼻咽喉 | 67篇 |
儿科学 | 200篇 |
妇产科学 | 96篇 |
基础医学 | 611篇 |
口腔科学 | 83篇 |
临床医学 | 585篇 |
内科学 | 983篇 |
皮肤病学 | 53篇 |
神经病学 | 602篇 |
特种医学 | 324篇 |
外科学 | 551篇 |
综合类 | 263篇 |
一般理论 | 5篇 |
预防医学 | 487篇 |
眼科学 | 137篇 |
药学 | 506篇 |
1篇 | |
中国医学 | 1篇 |
肿瘤学 | 228篇 |
出版年
2023年 | 34篇 |
2022年 | 86篇 |
2021年 | 217篇 |
2020年 | 78篇 |
2019年 | 132篇 |
2018年 | 166篇 |
2017年 | 109篇 |
2016年 | 141篇 |
2015年 | 121篇 |
2014年 | 174篇 |
2013年 | 248篇 |
2012年 | 251篇 |
2011年 | 225篇 |
2010年 | 205篇 |
2009年 | 188篇 |
2008年 | 181篇 |
2007年 | 237篇 |
2006年 | 195篇 |
2005年 | 204篇 |
2004年 | 158篇 |
2003年 | 143篇 |
2002年 | 152篇 |
2001年 | 123篇 |
2000年 | 148篇 |
1999年 | 137篇 |
1998年 | 93篇 |
1997年 | 80篇 |
1996年 | 56篇 |
1995年 | 57篇 |
1994年 | 65篇 |
1993年 | 69篇 |
1992年 | 86篇 |
1991年 | 72篇 |
1990年 | 74篇 |
1989年 | 93篇 |
1988年 | 74篇 |
1987年 | 75篇 |
1986年 | 81篇 |
1985年 | 71篇 |
1984年 | 63篇 |
1983年 | 41篇 |
1982年 | 56篇 |
1981年 | 35篇 |
1980年 | 43篇 |
1979年 | 35篇 |
1978年 | 25篇 |
1977年 | 34篇 |
1976年 | 25篇 |
1975年 | 27篇 |
1974年 | 28篇 |
排序方式: 共有5783条查询结果,搜索用时 234 毫秒
1.
2.
3.
4.
5.
顺铂聚乳酸微球的药物释放特性及肝动脉栓塞研究 总被引:5,自引:0,他引:5
对顺铂聚乳酸微球进行了体外药物释放和家犬肝动脉栓塞研究。该微球粒径范围为50~200μm,平均粒径为115.76±35.94μm,顺铂含量为37.16%(W/W);体外药物释放机制符合Higuchi方程;肝动脉栓塞后8h,肝组织顺铂浓度高达21.55±12.18μg/g,明显高于肝动脉灌注顺铂组:3.16±0.09μg/g(P<0.05);肝动脉栓塞组的顺铂血浓峰值、各取血点浓度及曲线下面积AUC皆低于肝动脉灌注顺铂组。可望达到提高栓塞部位的药物疗效,降低全身毒副反应的作用。 相似文献
6.
PC Chamyal A Mehta SL Ojha JR Bhardwaj 《Indian journal of otolaryngology and head and neck surgery》1991,43(1):26-27
Primary tuberculous pathology in nasolpolypi is a rare condition. A case of bilateral ethmoidal polypi with tubercular lesion diagnosed on histopathologlcal examination is being reported and the available relevant literature has been reviewed. 相似文献
7.
K Parsi T Exner D E Connor D D F Ma J E Joseph 《European journal of vascular and endovascular surgery》2007,34(6):731-740
OBJECTIVES: To investigate the in vitro effects of Sodium Tetradecyl Sulphate (STS) and Polidocanol (POL) on clotting tests, clotting factors, platelets and microparticles. MATERIALS AND METHODS: Platelet rich (PRP) and platelet poor (PPP) plasmas were incubated with varying concentrations of STS and POL. Clotting tests, platelet/plasma turbidity, and microparticle studies were performed. Specimens were mixed with individual factor deficient plasmas and clotting factor activities were studied. RESULTS: STS at high concentrations (>0.3%) destroyed platelets, microparticles and the clotting factors V, VII and X. It prolonged all clotting tests including prothrombin time (PT), activated partial thromboplastin time (APTT), non-activated partial thromboplastin time (NAPTT), thrombin time (TT), factor Xa clotting time (XACT) and surface activated clotting time (SACT). Higher concentrations of POL were required to achieve some anticoagulant activity. Low sclerosant concentrations shortened XACT and SACT, and induced release of procoagulant platelet derived microparticles. Increased exposure time resulted in increased procoagulant activity. STS at concentrations higher than 0.5% precipitated a complex containing apolipoprotein b and fibrinogen. CONCLUSIONS: Detergent sclerosants affect the clotting mechanism by interfering with clotting factor activities, procoagulant phospholipids and platelet derived microparticles. STS has more anticoagulant activity than POL in high concentrations. Low concentration sclerosants demonstrate procoagulant activity. 相似文献
8.
Denise M Connor Shawn Binkley Neil O Fishman Leanne B Gasink Darren Linkin Ebbing Lautenbach 《Infection control and hospital epidemiology》2007,28(12):1408-1410
We examined the possible unintended consequences of a 72-hour automatic order to discontinue vancomycin therapy in an antimicrobial stewardship program (ASP). Of 120 patients, 11 had vancomycin therapy discontinued at 72 hours without a call to the ASP, and 7 experienced a treatment interruption of 6-36 hours. All discontinuation of therapy was considered appropriate, and the 7 treatment interruptions did not have clear clinical consequences. Only one-third of patients had ASP stickers that warned of impending discontinuation of vancomycin therapy placed appropriately in the medical record. 相似文献
9.
10.
Several unique methodological challenges exist concerning the choice of the most appropriate comparator or control group for clinical research in complementary and alternative medicine (CAM). This article reviews the four major types of control groups (active control, placebo or sham, no intervention control, and different protocols of the experimental intervention), noting the different questions they answer and the different contexts in which they may be used, and discusses how this framework may be applied to CAM research in an effort to avoid methodologically flawed study designs. The choice of comparator depends on complex factors such as the research question being asked, the most plausible competing rival hypotheses, and logistical considerations related to ethics, methodology and feasibility. For example, for sham to be an effective comparator it must capture the ‘nonspecific’ elements of the treatment without containing those that are ‘specific’ to the research question at hand. However, as demonstrated by the examples of acupuncture and energy medicine, designing such sham intervention is not always easy. Controlling for social interaction between practitioners and subjects, addressing issues around ethics, having good-quality measurement of treatment integrity and intensity, and selecting practitioners of sufficient competence when doing a sham process are other important parts of correct design choices. In the light of these complexities, clinicians and researchers alike need a better match between the research questions and the design employed in order for their research to be both scientifically valid and clinically meaningful. 相似文献